Sri Nataraj Kalakonda

Employment

• Shri Vishnu College of Pharmacy Associate Professor
  2010 - Present
• Chaitanya College of Pharmacy Education and Research Professor and Principal
  2010 - 2010
• Chaitanya College of Pharmacy Education and Research Associate Professor
  2009 - 2010
• SRR College of Pharmaceutical Sciences Asst.Professor
  2005 - 2014
• Rural College of Pharmacy Lecturer
  2000 - 2005

Education

• Vel’s College of Pharmacy, Dr. M.G.R Medical University M. Pharm
  1998 - 2000
• S. C. S. College of Pharmacy B. Pharm
  1994 - 1998
• Vishnu Audio Visual Academy – A.U. Audio &Visual Communication
  ? - 2012
• JNT University, R&D Cell Ph. D
  ? - 2010

Projects & Funding

Projects & funding information is unavailable.

Publications (67)

• Green Indicators-An Ecofriendly Endpoint
  International Journal of Pharmaceutical Investigation 2023 DOI: 10.5530/ijpi.13.2.028
  +Save
• Bio-Analytical Method Development and Validation of Asciminib and its Application to Pharmacokinetic Studies in Rat Plasma by Using RP-HPLC
  Asian Journal of Chemistry 2023 DOI: 10.14233/ajchem.2023.27925
  +Save
• Biosensors – An Insight into the Electrochemical and Optical Biosensors
  International Journal of Pharmaceutical Investigation 2023 DOI: 10.5530/ijpi.13.3.051
  +Save
• Ternary System of Bacogenins with Fulvic Acid and Hydrogenated Soy Lecithin: Preparation, Characterization and, In vivo Studies
  Current Topics in Medicinal Chemistry 2022 DOI: 10.2174/1568026621666211111155425
  +Save
• Exploration of Fulvic Acid as a Co-Former in Crystal Engineering
  Separations 2022 DOI: 10.3390/separations9050126
  +Save
• Exploration of Fulvic acid as a functional excipient in line with the regulatory requirement.
  Environmental Research 2020 DOI: https://doi.org/10.1016/j.envres.2020.109642
  +Save
• Residual analytical Method development and validation of Doripenem for Injection for cleaning validation
  Advanced Science Letters 2020
  +Save
• A regulatory strategy by keeping the same batch size for commercial that of exhibit batches may have untold advantages over traditional approach when filing an ANDA for an immediate release tablet dosage form
  International Journal of Pharmacy and Biological Sciences 2019
  +Save
• Analytical method development & validation of Metformin, Pioglitazone & Glimepiride by RP-HPLC in tablet dosage forms
  The Pharma Innovation Journal 2019
  +Save
• A regulatory strategy at the time of an ANDA submission for a solid oral dosage form by manufacturing one small scale batch among the three exhibit batches may bring cost savings in addition to preventing potential refuse to receive from the FDA
  International Journal of Pharmacy and Biological Sciences 2018
  +Save